Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.56 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.50 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 2/20 | 0.41 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.41 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18062416 | 0.89 | TRPA1 (0.55) | TRPA1TAAR1AOC3RIPK1LMNA | |
| SCHEMBL6285816 | 0.89 | TRPA1 (0.58) | TRPA1TAAR1AOC3RIPK1LMNA | |
| SCHEMBL3672929 | 0.87 | TRPA1 (0.67) | TRPA1TAAR1AOC3RIPK1HRH1 | |
| SCHEMBL9479604 | 0.87 | TRPA1 (0.68) | TRPA1TAAR1AOC3RIPK1KDM4E | |
| SCHEMBL9479600 | 0.87 | TRPA1 (0.52) | TRPA1TAAR1AOC3RIPK1 | |
| SCHEMBL6956036 | 0.87 | TRPA1 (0.52) | TRPA1TAAR1AOC3RIPK1HRH1 | |
| SCHEMBL29678203 | 0.87 | TRPA1 (0.53) | TRPA1TAAR1AOC3RIPK1 | |
| SCHEMBL6801631 | 0.83 | TRPA1 (0.50) | TRPA1TAAR1AOC3RIPK1CHRM2 | |
| SCHEMBL21164200 | 0.83 | TRPA1 (0.46) | TRPA1TAAR1RIPK1SLC6A3KCNH2 | |
| SCHEMBL4895660 | 0.83 | TRPA1 (0.46) | TRPA1TAAR1RIPK1SLC6A3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120281179-A1 | Electro-Thermal Antifog Optical Devices | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2012-11-08 | — | — | US | disclosed |
| CN-102746104-A | Synthesizing method of 1,4-diphenylbutane | UNIV TIANJIN | 2012-10-24 | — | — | CN | disclosed |
| CN-102659503-A | Preparing method of 2, 3-diphenyl butane | UNIV TIANJIN | 2012-09-12 | — | — | CN | disclosed |
| US-7781599-B2 | economical; nontoxic; high yield; industrial scale; Grignard reaction; iron catalyst (FeCl3) and a diamine (ethylenediamine); cross-coupling of alkyl halide and aromatic organometallic; primary or secondary alkyl substituents; phenylcycloheptane from bromocycloheptane and phenyl magnesium bromide | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20070123734-A1 | Process for production of aromatic compounds | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 2007-05-31 | — | — | US | disclosed |
| EP-1724248-A1 | PROCESS FOR PRODUCTION OF AROMATIC COMPOUNDS | Japan Science and Technology Agency (JP) | 2006-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123734-A1 | Process for production of aromatic compounds | C9, C5, C1S | TRPA1 135/4885TAAR1 261/4885AOC3 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.